In MCF7 cells, oestrogen treatment stabilizes the 105 kDa Nedd9 form and suppresses the ability of Nedd9 to induce cell spreading, thus suggesting that Nedd9 phosphorylation status might be an indicator of breast cancer cell motility in response to oestrogens [32]. This evidence concerns the gene NEDD9 and breast carcinoma.